Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
Sension, Michael G., Brunet, Laurence, Hsu, Ricky K., Fusco, Jennifer S., Cochran, Quateka, Uranaka, Christine, Sridhar, Gayathri, Vannappagari, Vani, Van Wyk, Jean, McCurdy, Lewis, Wohlfeiler, Michael B., Fusco, Gregory P.
Published in Infectious diseases and therapy (01.12.2023)
Published in Infectious diseases and therapy (01.12.2023)
Get full text
Journal Article
HIV retention in care: results and lessons learned from the Positive Pathways Implementation Trial
Wohlfeiler, Michael B, Weber, Rachel Palmieri, Brunet, Laurence, Fusco, Jennifer S, Uranaka, Christine, Cochran, Quateka, Palma, Monica, Evans, Tammeka, Millner, Carl, Fusco, Gregory P
Published in BMC family practice (23.11.2022)
Published in BMC family practice (23.11.2022)
Get full text
Journal Article
1582. Real-World Use of Long-Acting Cabotegravir + Rilpivirine in the US: Effectiveness in the First Year
Sension, Michael G, Hsu, Ricky K, Fusco, Jennifer S, Brunet, Laurence, Cochran, Quateka, Uranaka, Christine, Sridhar, Gayathri, Vannappagari, Vani, Zolopa, Andrew, van Wyk, Jean A, McCurdy, Lewis, Fusco, Gregory P, Wohlfeiler, Michael B
Published in Open forum infectious diseases (15.12.2022)
Published in Open forum infectious diseases (15.12.2022)
Get full text
Journal Article